Logo image
Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome
Journal article   Open access   Peer reviewed

Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome

Fengxiao Bu, Tara Maga, Nicole C Meyer, Kai Wang, Christie P Thomas, Carla M Nester and Richard J H Smith
Journal of the American Society of Nephrology, Vol.25(1), pp.55-64
01/2014
DOI: 10.1681/ASN.2013050453
PMCID: PMC3871781
PMID: 24029428
url
https://doi.org/10.1681/ASN.2013050453View
Published (Version of record) Open Access

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy caused by uncontrolled activation of the alternative pathway of complement at the cell surface level that leads to microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney failure. In approximately one half of affected patients, pathogenic loss-of-function variants in regulators of complement or gain-of-function variants in effectors of complement are identified, clearly implicating complement in aHUS. However, there are strong lines of evidence supporting the presence of additional genetic contributions to this disease. To identify novel aHUS-associated genes, we completed a comprehensive screen of the complement and coagulation pathways in 36 patients with sporadic aHUS using targeted genomic enrichment and massively parallel sequencing. After variant calling, quality control, and hard filtering, we identified 84 reported or novel nonsynonymous variants, 22 of which have been previously associated with disease. Using computational prediction methods, 20 of the remaining 62 variants were predicted to be deleterious. Consistent with published data, nearly one half of these 42 variants (19; 45%) were found in genes implicated in the pathogenesis of aHUS. Several genes in the coagulation pathway were also identified as important in the pathogenesis of aHUS. PLG, in particular, carried more pathogenic variants than any other coagulation gene, including three known plasminogen deficiency mutations and a predicted pathogenic variant. These data suggest that mutation screening in patients with aHUS should be broadened to include genes in the coagulation pathway.
Hemolytic-Uremic Syndrome - etiology Genetic Testing Humans Hemolytic-Uremic Syndrome - blood Child, Preschool Molecular Sequence Data Plasminogen - genetics Male Thrombotic Microangiopathies - genetics DNA Copy Number Variations Genetic Variation Young Adult Hemolytic-Uremic Syndrome - genetics Conserved Sequence Adult Complement System Proteins - genetics Female Thrombotic Microangiopathies - blood Complement Pathway, Alternative - genetics Child Thrombotic Microangiopathies - immunology Amino Acid Sequence Sequence Homology, Amino Acid Adolescent Blood Coagulation - genetics Mutation Atypical Hemolytic Uremic Syndrome Plasminogen - deficiency

Details

Metrics

Logo image